Deswal Anita, Petersen Nancy J, Urbauer Diana L, Wright Steven M, Beyth Rebecca
Houston Center for Quality of Care and Utilization Studies, Michael E. DeBakey Veterans Affairs Medical Center, Baylor College of Medicine, Houston, TX 77030, USA
Am Heart J. 2006 Aug;152(2):348-54. doi: 10.1016/j.ahj.2005.12.004.
Few recent studies have demonstrated similar quality of care for hospitalized black and white patients with heart failure (HF). However, systematic evaluation of racial differences in both the quality of care and outcomes is needed in the outpatient setting, where most patients with HF are treated and where care may be more fragmented.
We examined racial differences in quality-of-care measures and outcomes of 1-year mortality and hospitalization in a national cohort of 18,611 ambulatory patients with HF treated at Veterans Affairs medical centers between October 2000 and September 2002.
Black patients were more likely to have left ventricular ejection fraction assessment than whites (risk-adjusted OR 1.29, 95% CI 1.11-1.49). In patients with left ventricular ejection fraction <40%, blacks were as likely as whites to be on treatment with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers (risk-adjusted OR 1.06, 95% CI 0.85-1.33) and beta-blockers (risk-adjusted OR 0.92, 95% CI 0.79-1.07). However, black patients more frequently had uncontrolled hypertension and were more likely to be hospitalized for any cause (OR 1.20, 95% CI 1.08-1.33) or for HF (OR 1.43, 95% CI 1.23-1.66), although 1-year mortality did not differ by race (OR 1.03, 95% CI 0.89-1.20).
In a financially "equal access" health care system, the quality of outpatient HF care assessed by select quality measures and 1-year mortality was similar in black compared to white patients. However, blacks were more likely to be hospitalized, especially with HF. Identifying and targeting potentially modifiable factors such as uncontrolled hypertension in black patients may narrow the racial gap in hospitalizations.
近期很少有研究表明,住院的黑人和白人心力衰竭(HF)患者获得的医疗护理质量相似。然而,在门诊环境中,需要对医疗护理质量和治疗结果方面的种族差异进行系统评估,因为大多数HF患者在门诊接受治疗,且门诊护理可能更加分散。
我们在2000年10月至2002年9月期间于退伍军人事务医疗中心接受治疗的18611名门诊HF患者的全国队列中,研究了医疗护理质量指标以及1年死亡率和住院率方面的种族差异。
黑人患者比白人患者更有可能接受左心室射血分数评估(风险调整后的比值比为1.29,95%置信区间为1.11 - 1.49)。在左心室射血分数<40%的患者中,黑人患者使用血管紧张素转换酶抑制剂或血管紧张素受体阻滞剂进行治疗的可能性与白人患者相同(风险调整后的比值比为1.06,95%置信区间为0.85 - 1.33),使用β受体阻滞剂进行治疗的可能性也与白人患者相同(风险调整后的比值比为0.92,95%置信区间为0.79 - 1.07)。然而,黑人患者中未控制的高血压更为常见,并且因任何原因住院的可能性更大(比值比为1.20,95%置信区间为1.08 - 1.33),因HF住院的可能性也更大(比值比为1.43,95%置信区间为1.23 - 1.66),尽管1年死亡率在种族之间没有差异(比值比为1.03,95%置信区间为0.89 - 1.20)。
在一个经济上“平等就医”的医疗保健系统中,通过选定的质量指标评估的门诊HF护理质量以及1年死亡率在黑人患者和白人患者中相似。然而,黑人患者住院的可能性更大,尤其是因HF住院。识别并针对黑人患者中未控制的高血压等潜在可改变因素,可能会缩小住院方面的种族差距。